OSU College of Pharmacy faculty member and researcher Dr. Gaurav Sahay’s has been a leader in the field of mRNA-based therapeutics. His lab has made a significant contribution to the development of lipid-based nanoparticles for the delivery of mRNA based therapeutics and vaccines. In the past, Dr. Sahay has had collaborations with Moderna Tx which led to seminal publications in Nature Communications, Nano Letters, and patents. Sahay lab pivoted to develop mRNA based therapeutics that may have the potential to treat COVID during the pandemic. Dr. Sahay’s expertise has been called by local reporting agencies as a subject matter expert to help explain the vaccine to the public.
KGW>>>
Koin 6 News>>>
Science Magazine>>>
C&EN>>>
Categories
Dr. Gaurav Sahay’s mRNA-based Therapeutics Research Contributed to the COVID-19 Vaccine Development
